Articles by admin

No Picture
Trading Ideas

After a Massive Gain, Is There Still Room for Adaptimmune (ADAP) Stock to Soar?

January 14, 2020 admin Comments Off on After a Massive Gain, Is There Still Room for Adaptimmune (ADAP) Stock to Soar?

In a single day, the talk on the Street has zeroed in on one stock, oncology-focused cell therapy company Adaptimmune Therapeutics (ADAP). Following its presentation of promising data at the 38th annual J.P. Morgan Healthcare Conference, shares took off, posting a whopping 200% one-day gain.The data revealed that its MAGE-A4 (ADP-A2M4 and next-generation ADP-A2M4CD8) and AFP (ADP-A2AFP) therapies, part of its SPEAR T-cell platform, demonstrated initial solid tumor responses in four indications: gastro-esophageal junction, head and neck, liver cancers and melanoma.“These responses demonstrate that our proprietary SPEAR T-cell platform is clearly active and can overcome the challenges of treating a …read more […]

No Picture
Trading Ideas

Boeing net orders slump to lowest in decades

January 14, 2020 admin Comments Off on Boeing net orders slump to lowest in decades

Allowing for cancellations and changes to earlier orders, Chicago-based Boeing said it had received just 54 new orders for planes in 2019 and delivered less than half as many as a year earlier, losing the top spot to its European rival for the first time in eight years. Ten months after the MAX was grounded following a pair of fatal crashes linked to its MCAS anti-stall system, Boeing still has a backlog of more than 5,400 orders for its long- and short-distance commercial jets. Boeing said on Tuesday deliveries fell by 53% to 380 planes over the whole …read more […]

No Picture
Business News

U.S. Supreme Court tosses lower court ruling that allowed IBM retirement fund suit

January 14, 2020 admin Comments Off on U.S. Supreme Court tosses lower court ruling that allowed IBM retirement fund suit

The U.S. Supreme Court on Tuesday threw out a lower court ruling that allowed a lawsuit to proceed against managers of a retirement fund for IBM Corp employees centering on allegations that officials failed to disclose that IBM’s microelectronics business was over-valued.

…read more […]